Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
31.50
+0.08 (0.25%)
At close: Jun 26, 2026, 4:00 PM EDT
31.39
-0.11 (-0.35%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Catalyst Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Catalyst Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $31.67. The average 1-year stock price forecast is 0.54% higher than the current stock price, while the lowest is $31.5 (0.00%) and the highest is $32 (+1.59%).
Price Target: $31.67 (+0.54%)
Analyst Consensus: Hold
* Price targets were last updated on May 28, 2026.
Analyst Ratings
The average analyst rating for Catalyst Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Hold Downgrades $35 → $32 | Hold | Downgrades | $35 → $32 | n/a | May 28, 2026 |
| Citi | Citi | Hold Downgrades $35 → $32 | Hold | Downgrades | $35 → $32 | n/a | May 8, 2026 |
Unknown Analyst Robert W. Baird No rating | Robert W. Baird | Hold Downgrades $32 | Hold | Downgrades | $32 | +1.59% | May 7, 2026 |
| Oppenheimer | Oppenheimer | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 7, 2026 |
| Stephens | Stephens | Hold Downgrades $32 | Hold | Downgrades | $32 | +1.59% | May 7, 2026 |
Financial Forecast
Revenue This Year
636.20M
from 588.99M
Increased by 8.02%
Revenue Next Year
717.90M
from 636.20M
Increased by 12.84%
EPS This Year
3.17
from 2.72
Increased by 16.69%
EPS Next Year
3.18
from 3.17
Increased by 0.22%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 640.2M | ||
| Avg | 636.2M | ||
| Low | 632.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 8.7% | ||
| Avg | 8.0% | ||
| Low | 7.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.17 | ||
| Avg | 3.17 | ||
| Low | 3.17 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.7% | ||
| Avg | 16.7% | ||
| Low | 16.7% |